Non-interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions

Trial Profile

Non-interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Apr 2017

At a glance

  • Drugs Vismodegib (Primary)
  • Indications Basal cell cancer
  • Focus Therapeutic Use
  • Acronyms JONAS
  • Most Recent Events

    • 01 Apr 2017 Planned End Date changed from 1 Apr 2020 to 1 Apr 2021.
    • 01 Apr 2017 Planned primary completion date changed from 1 Apr 2020 to 1 Apr 2021.
    • 02 Jul 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top